9 November 2019 Social Media Post: Effective Treatment of Midlife Hypertension

Fascinating The Lancet Neurology article showing that effective treatment of midlife hypertension can reduce the risk of Alzheimer Disease by 16% and overall dementia by 12%.

Meta-Analysis: Hypertension Treatment Tied to Lower Risk for Dementia, Alzheimer's

By Amy Orciari Herman

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS


Antihypertensive treatment is associated with lower risk for dementia in older adults with high blood pressure, a meta-analysis in the Lancet Neurology finds.

Researchers combined data from six prospective studies comprising over 30,000 adults aged 55 and older who were dementia-free at baseline. During a median follow-up of 7 to 22 years, roughly 3700 developed dementia, nearly half of whom developed Alzheimer disease.

Among participants with hypertension, those who used any antihypertensive agent had a 12% lower risk for dementia and a 16% lower risk for Alzheimer’s relative to those not using antihypertensives. No antihypertensive class emerged as superior to others.

Antihypertensive treatment was not associated with reduced dementia risk among participants with normal or pre-hypertensive blood pressure. This group probably included patients with well-controlled hypertension.

Commentators say that with these data, taken together with other analyses, “there is now persuasive evidence for a beneficial effect of blood pressure lowering on cognitive function from treatment initiated in midlife.”

𝗦𝗶𝗴𝗻 𝗨𝗽 𝗳𝗼𝗿 𝗢𝘂𝗿 𝗡𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿

Dig deeper into the health topics you care about most by signing up for our newsletter.

by submitting this form you indicate you have
read and agree to our Privacy Policy and Terms
of Use. Please contact us to for us for more

Recommended Posts

No comment yet, add your voice below!

Add a Comment

Your email address will not be published. Required fields are marked *